Literature DB >> 11320622

[Treatment of therapy refractory chronic otitis externa by local injection of triamcinolone acetate crystalline suspension. Initial experiences].

B A Stuck1, F Riedel, K Hörmann.   

Abstract

BACKGROUND AND
OBJECTIVE: External otitis is characterized by otalgia, otorrhea, itching, and hearing loss. Treatment usually consists of local application of corticosteroids and antibiotics. Chronic external otitis is accompanied by thickening of the skin in the external auditory channel. This reduces the effect of the applied substances. Local injection of suitable drugs may support the conservative treatment. The aim of the study was to evaluate the efficacy of local injection of triamcinolone acetonide in the external auditory channel. PATIENTS/
METHODS: Thirteen patients with external otitis resistant to conservative treatment received an injection of triamcinolone acetonide in the external auditory channel. The improvement achieved was assessed by clinical examination and questionnaires.
RESULTS: The symptoms improved substantially in all patients; most of the patients were cured completely.
CONCLUSIONS: Our results demonstrate that local injection of triamcinolone acetonide is effective in the management of chronic external otitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11320622     DOI: 10.1007/s001060050733

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  2 in total

1.  [Topical immunomodulation. A milestone for the treatment of therapy-resistant noninfectious chronic external otitis?].

Authors:  P P Caffier; W Harth; B Mayelzadeh; H Haupt; H Scherer; B Sedlmaier
Journal:  HNO       Date:  2008-05       Impact factor: 1.284

2.  Topical treatment of acute otitis externa: clinical comparison of an antibiotics ointment alone or in combination with hydrocortisone acetate.

Authors:  Ralph Mösges; Christian M Domröse; Jürgen Löffler
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-05-15       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.